Artículos de revistas sobre el tema "HCV"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "HCV".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
CRAMP, M. E. "HBV + HCV = HCC?" Gut 45, n.º 2 (1 de agosto de 1999): 168–69. http://dx.doi.org/10.1136/gut.45.2.168.
Texto completoMujeeb, Syed Abdul, Qamar Jamal, Rafique Khanani, Nayyer Iqbal y Shahnaz Kaher. "Prevalence of Hepatitis B Surface Antigen and HCV Antibodies in Hepatocellular Carcinoma Cases in Karachi, Pakistan". Tropical Doctor 27, n.º 1 (enero de 1997): 45–46. http://dx.doi.org/10.1177/004947559702700117.
Texto completoStroffolini, Tommaso y Giacomo Stroffolini. "A Historical Overview on the Role of Hepatitis B and C Viruses as Aetiological Factors for Hepatocellular Carcinoma". Cancers 15, n.º 8 (20 de abril de 2023): 2388. http://dx.doi.org/10.3390/cancers15082388.
Texto completoHuang, Yen-Tsung, Chin-Lan Jen, Hwai-I. Yang, Mei-Hsuan Lee, Jun Su, Sheng-Nan Lu, Uchenna H. Iloeje y Chien-Jen Chen. "Lifetime Risk and Sex Difference of Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B and C". Journal of Clinical Oncology 29, n.º 27 (20 de septiembre de 2011): 3643–50. http://dx.doi.org/10.1200/jco.2011.36.2335.
Texto completoPár, Alajos. "Prophylaxis and treatment of chronic viral hepatitis as the prevention of hepatocellular carcinoma". Orvosi Hetilap 150, n.º 1 (1 de enero de 2009): 19–26. http://dx.doi.org/10.1556/oh.2009.28529.
Texto completoHaberl, Elisabeth M., Thomas S. Weiss, Georg Peschel, Kilian Weigand, Nikolai Köhler, Josch K. Pauling, Jürgen J. Wenzel et al. "Liver Lipids of Patients with Hepatitis B and C and Associated Hepatocellular Carcinoma". International Journal of Molecular Sciences 22, n.º 10 (18 de mayo de 2021): 5297. http://dx.doi.org/10.3390/ijms22105297.
Texto completoFang, Lily, Amanda Yu y Jane A. Buxton. "Identification of Acute Vaccine-Preventable Hepatitis in Individuals with Chronic Hepatitis in British Columbia between 1991 and 2007". Canadian Journal of Infectious Diseases and Medical Microbiology 22, n.º 1 (2011): 10–14. http://dx.doi.org/10.1155/2011/564290.
Texto completoBuxton, Jane A. y Jin Hee Kim. "Hepatitis A and Hepatitis B Vaccination Responses in Persons with Chronic Hepatitis C Infections: A Review of the Evidence and Current Recommendations". Canadian Journal of Infectious Diseases and Medical Microbiology 19, n.º 2 (2008): 197–202. http://dx.doi.org/10.1155/2008/410362.
Texto completoShen, Yu-Chuan, Hui-Ching Hsu, Tzu-Min Lin, Yu-Sheng Chang, Li-Fang Hu, Lung-Fang Chen, Sheng-Hong Lin et al. "H1-Antihistamines Reduce the Risk of Hepatocellular Carcinoma in Patients With Hepatitis B Virus, Hepatitis C Virus, or Dual Hepatitis B Virus-Hepatitis C Virus Infection". Journal of Clinical Oncology 40, n.º 11 (10 de abril de 2022): 1206–19. http://dx.doi.org/10.1200/jco.21.01802.
Texto completoAlhamadany, Alaa Younis Mahdy y Wajdi Sabeeh Sadek. "Analysis of the Chromosomal Aberrations in Hepatitis B Virus (HBV), Hepatitis C Virus (HCV), and Hepatocellular Carcinoma Patients (HCC) in Mosul City, Iraq". NTU Journal of Pure Sciences 1, n.º 2 (31 de mayo de 2022): 48–53. http://dx.doi.org/10.56286/ntujps.v1i2.210.
Texto completoKuo, Yuan-Hung, Tzu-Hsin Huang, Jing-Houng Wang, Yen-Yang Chen, Ming-Chao Tsai, Yen-Hao Chen, Sheng-Nan Lu, Tsung-Hui Hu, Chien-Hung Chen y Chao-Hung Hung. "Well-Controlled Viremia Predicts the Outcome of Hepatocellular Carcinoma in Chronic Viral Hepatitis Patients Treated with Sorafenib". Cancers 14, n.º 16 (17 de agosto de 2022): 3971. http://dx.doi.org/10.3390/cancers14163971.
Texto completoAlhamadany, Alaa Younis Mahdy y Wajdi Sabeeh Sadek. "Evaluation of the genotoxicity in patients with HBV, HCV, and HCC using micronucleus and comet assay in Mosul City\Iraq". International journal of health sciences 6, S1 (20 de marzo de 2022): 1567–79. http://dx.doi.org/10.53730/ijhs.v6ns1.4903.
Texto completoMbaga, Donatien Serge, Sebastien Kenmoe, Cyprien Kengne-Ndé, Jean Thierry Ebogo-Belobo, Gadji Mahamat, Joseph Rodrigue Foe-Essomba, Marie Amougou-Atsama et al. "Hepatitis B, C and D virus infections and risk of hepatocellular carcinoma in Africa: A meta-analysis including sensitivity analyses for studies comparable for confounders". PLOS ONE 17, n.º 1 (21 de enero de 2022): e0262903. http://dx.doi.org/10.1371/journal.pone.0262903.
Texto completoAlhamadany, Alaa Younis Mahdy y Wajdi Sabeeh Sadek. "Evaluation of the genotoxicity and genomic instability in patients with HBV, HCV and HCC using micronucleus and comet assay". NTU Journal of Pure Sciences 1, n.º 2 (31 de mayo de 2022): 54–63. http://dx.doi.org/10.56286/ntujps.v1i2.214.
Texto completoDickson-Spillmann, Maria, Severin Haug, Ambros Uchtenhagen, Philip Bruggmann y Michael P. Schaub. "Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection". European Addiction Research 22, n.º 4 (11 de diciembre de 2015): 181–91. http://dx.doi.org/10.1159/000441973.
Texto completoNavas, Maria-Cristina, Iris Suarez, Andrea Carreño, Diego Uribe, Wilson Alfredo Rios, Fabian Cortes-Mancera, Ghyslaine Martel et al. "Hepatitis B and Hepatitis C Infection Biomarkers and TP53 Mutations in Hepatocellular Carcinomas from Colombia". Hepatitis Research and Treatment 2011 (31 de octubre de 2011): 1–10. http://dx.doi.org/10.1155/2011/582945.
Texto completoMinuk, GY, M. Zhang, SGM Wong, J. Uhanova, CN Bernstein, B. Martin, MR Dawood, L. Vardy y A. Giulvi. "Viral Hepatitis in a Canadian First Nations Community". Canadian Journal of Gastroenterology 17, n.º 10 (2003): 593–96. http://dx.doi.org/10.1155/2003/978162.
Texto completoLu, Meng-Chuan, Ying-Hsuen Wu, Chi-Hsiang Chung, Hsuan-Hwai Lin, Tsai-Yuan Hsieh, Peng-Jen Chen, Wu-Chien Chien y Hsuan-Wei Chen. "Association of Hepatitis B and C Virus with the Risk of Coronary Artery Disease and Cerebrovascular Disease in Patients with Hepatocellular Carcinoma". Journal of Clinical Medicine 12, n.º 7 (30 de marzo de 2023): 2602. http://dx.doi.org/10.3390/jcm12072602.
Texto completoDuan, Jingxian, Tianhao Mu y Shifu Chen. "The mutation profiles of HBV or HCV infected hepatocellular carcinoma patients underlie the varied responses to second-line immunotherapy." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): e16629-e16629. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e16629.
Texto completoSchotten, Clemens, Bastian Ostertag, Jan-Peter Sowa, Paul Manka, Lars P. Bechmann, Gudrun Hilgard, Claudio Marquardt et al. "GALAD Score Detects Early-Stage Hepatocellular Carcinoma in a European Cohort of Chronic Hepatitis B and C Patients". Pharmaceuticals 14, n.º 8 (27 de julio de 2021): 735. http://dx.doi.org/10.3390/ph14080735.
Texto completoRahman, Md Tahminur, Rosy Sultana y Sohel Reza Chowdhury. "Seropositivity and pattern of viral hepatitis in clinically suspected cases of hepatitis in Dhaka city". Bangladesh Medical Research Council Bulletin 33, n.º 3 (15 de septiembre de 2010): 103–6. http://dx.doi.org/10.3329/bmrcb.v33i3.1142.
Texto completoAlqahtani, Saleh A. y Massimo Colombo. "Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma". Cells 10, n.º 11 (9 de noviembre de 2021): 3091. http://dx.doi.org/10.3390/cells10113091.
Texto completoShao, Yu Yun, Min-Shu Hsieh, Chung-Yi Huang, Yung-Ling Chang, Chih-Hung Hsu y Ann-Lii Cheng. "Vascular endothelial growth factor expression in hepatitis C virus (HCV)-related advanced hepatocellular carcinoma (HCC) compared with hepatitis B virus (HBV)-related advanced HCC." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): 4115. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.4115.
Texto completoGaly, Olivier, Isabelle Chemin, Emilie Le Roux, Stéphanie Villar, Florence Le Calvez-Kelm, Myriam Lereau, Doriane Gouas et al. "Mutations in TP53 and CTNNB1 in Relation to Hepatitis B and C Infections in Hepatocellular Carcinomas from Thailand". Hepatitis Research and Treatment 2011 (30 de junio de 2011): 1–9. http://dx.doi.org/10.1155/2011/697162.
Texto completoAimla, Kerstin, Justyna Dominika Kowalska, Raimonda Matulionyte, Velida Mulabdic, Anna Vassilenko, Natalie Bolokadze, David Jilich et al. "Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group". Vaccines 11, n.º 5 (14 de mayo de 2023): 980. http://dx.doi.org/10.3390/vaccines11050980.
Texto completoHester, Caitlin A., Nicole E. Rich, Amit G. Singal y Adam C. Yopp. "Comparative Analysis of Nonalcoholic Steatohepatitis– Versus Viral Hepatitis– and Alcohol-Related Liver Disease–Related Hepatocellular Carcinoma". Journal of the National Comprehensive Cancer Network 17, n.º 4 (abril de 2019): 322–29. http://dx.doi.org/10.6004/jnccn.2018.7105.
Texto completoAkashi, Hayato y Masaaki Hidaka. "Comparison of the pathological features among HBV, HCV, and nonviral etiology-related hepatocellular carcinoma using explanted whole liver examinations." Journal of Clinical Oncology 35, n.º 4_suppl (1 de febrero de 2017): 245. http://dx.doi.org/10.1200/jco.2017.35.4_suppl.245.
Texto completoC, Nwangburuka, Ijomah M A y Nwakuya M T. "Heteroscedasticity of unknown form: a comparison of five heteroscedasticity-consistent covariance matrix (hccm) estimators". Global Journal of Pure and Applied Sciences 29, n.º 1 (16 de mayo de 2023): 83–90. http://dx.doi.org/10.4314/gjpas.v29i1.10.
Texto completoCortes-Mancera, Fabian, Carmen Luisa Loureiro, Sergio Hoyos, Juan-Carlos Restrepo, Gonzalo Correa, Sergio Jaramillo, Helene Norder, Flor Helene Pujol y Maria-Cristina Navas. "Etiology and Viral Genotype in Patients with End-Stage Liver Diseases admitted to a Hepatology Unit in Colombia". Hepatitis Research and Treatment 2011 (20 de septiembre de 2011): 1–10. http://dx.doi.org/10.1155/2011/363205.
Texto completoPatt, Y. Z., C. Charnsangavej, B. Yoffe, R. Smith, D. Lawrence, V. Chuang, H. Carrasco, M. Roh, J. Chase y H. Fischer. "Hepatic arterial infusion of floxuridine, leucovorin, doxorubicin, and cisplatin for hepatocellular carcinoma: effects of hepatitis B and C viral infection on drug toxicity and patient survival." Journal of Clinical Oncology 12, n.º 6 (junio de 1994): 1204–11. http://dx.doi.org/10.1200/jco.1994.12.6.1204.
Texto completoPetruzziello, Arnolfo. "Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma". Open Virology Journal 12, n.º 1 (28 de febrero de 2018): 26–32. http://dx.doi.org/10.2174/1874357901812010026.
Texto completoYen, Yi-Hao, Kwong-Ming Kee, Wei-Feng Li, Yueh-Wei Liu, Chih-Chi Wang, Tsung-Hui Hu, Ming-Chao Tsai, Yuan-Hung Kuo y Chih-Yun Lin. "Causes of Death among Patients with Hepatocellular Carcinoma According to Chronic Liver Disease Etiology". Cancers 15, n.º 6 (9 de marzo de 2023): 1687. http://dx.doi.org/10.3390/cancers15061687.
Texto completoTong, C. Y. W., R. Khan, N. J. Beeching, W. U. Z. Tariq, C. A. Hart, N. Ahmad y I. A. Malik. "The occurrence of hepatitis B and C viruses in Pakistani patients with chronic liver disease and hepatocellula carcinoma". Epidemiology and Infection 117, n.º 2 (octubre de 1996): 327–32. http://dx.doi.org/10.1017/s0950268800001503.
Texto completoQiu, Jinrong, Weifeng Wang, Yingmei Li y Shifu Chen. "Comparison of mutational landscape of non-alcoholic fatty liver disease, viral hepatitis, and alcohol consumption related hepatocellular carcinoma." Journal of Clinical Oncology 38, n.º 15_suppl (20 de mayo de 2020): e16614-e16614. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.e16614.
Texto completoPseush, S. Yu, L. V. Zozulya y L. L. Mikhaleva. "The predictive value indicators of first trimester biochemical screening in assessing unfavorable factors of pregnancy course in women with HIV as well as hepatitis B and C". Obstetrics, Gynecology and Reproduction 15, n.º 6 (12 de enero de 2022): 686–94. http://dx.doi.org/10.17749/2313-7347/ob.gyn.rep.2021.240.
Texto completoHuang, Xiao-wen, Bing Liao, Yang Huang, Jin-yu Liang, Quan-yuan Shan, Shun-li Shen, Xiao-yan Xie, Ming-de Lu, Li-da Chen y Wei Wang. "Non-Invasive Diagnostic Criteria for Hepatocellular Carcinoma in Hepatitis B Virus-Endemic Areas: Is Cirrhosis Indispensable?" Digestive Diseases 36, n.º 3 (2018): 228–35. http://dx.doi.org/10.1159/000486196.
Texto completoKishta, Sara, Ashraf Tabll, Tea Omanovic Kolaric, Robert Smolic y Martina Smolic. "Risk Factors Contributing to the Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Patients Treated with Direct-Acting Antivirals". Biomedicines 8, n.º 6 (25 de junio de 2020): 175. http://dx.doi.org/10.3390/biomedicines8060175.
Texto completoKanda, Tatsuo, Taichiro Goto, Yosuke Hirotsu, Mitsuhiko Moriyama y Masao Omata. "Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review". International Journal of Molecular Sciences 20, n.º 6 (18 de marzo de 2019): 1358. http://dx.doi.org/10.3390/ijms20061358.
Texto completoAlhaqbani, Abdulaziz H., Abdulaziz Almusalam, Abdulaziz Alnadhari, Abdulmalik Alsalem, Meshal Alrasheed, Abduljaleel Alalwan y Bander Aldamkh. "The prevalence and associated factors of viral hepatitis and cryptogenic related hepatocellular carcinoma at King Abdulaziz Medical city-Riyadh". International Journal Of Community Medicine And Public Health 6, n.º 2 (24 de enero de 2019): 561. http://dx.doi.org/10.18203/2394-6040.ijcmph20190060.
Texto completoHiggs, Martin R., Philippe Chouteau y Hervé Lerat. "‘Liver let die’: oxidative DNA damage and hepatotropic viruses". Journal of General Virology 95, n.º 5 (1 de mayo de 2014): 991–1004. http://dx.doi.org/10.1099/vir.0.059485-0.
Texto completoHsiao, Yi-Wen, Lu-Ting Chiu, Ching-Hsuan Chen, Wei-Liang Shih y Tzu-Pin Lu. "Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas". Genes 10, n.º 8 (20 de agosto de 2019): 630. http://dx.doi.org/10.3390/genes10080630.
Texto completoGlitscher, Mirco, Eberhard Hildt y Daniela Bender. "Hepatitis B und C: Mechanismen der virusinduzierten Leberpathogenese und Tumorentstehung". Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 65, n.º 2 (11 de enero de 2022): 228–37. http://dx.doi.org/10.1007/s00103-021-03482-y.
Texto completoMinuk, Gerald Y. y J. Uhanova. "Viral Hepatitis in the Canadian Inuit and First Nations Populations". Canadian Journal of Gastroenterology 17, n.º 12 (2003): 707–12. http://dx.doi.org/10.1155/2003/350175.
Texto completoSchaer, Robert, Fernanda Anjos Bastos, Juçara Magalhães Simões, Juvenal Encarnação Silva, Soraya Castro Trindade, Roberto José Meyer Nascimento, Songeli Menezes Freire y Maria Isabel Schinoni. "Seroprevalence of viral Hepatitis of enteric (A and E) and parenteral / sexual (B and C) transmission of individuals aged 30 to 70 residents in Salvador-Brazil". STUDIES IN HEALTH SCIENCES 3, n.º 2 (19 de mayo de 2022): 1095–111. http://dx.doi.org/10.54022/shsv3n2-037.
Texto completoKee, Kwong-Ming, Chien-Hung Chen, Jui-Ting Hu, Yi-Hsiang Huang, Tsang-En Wang, Gar-Yang Chau, Kuo-Hsin Chen et al. "Secular Trends of Clinical Characteristics and Survival of Hepatocellular Carcinoma in Taiwan from 2011 to 2019". Viruses 15, n.º 1 (31 de diciembre de 2022): 126. http://dx.doi.org/10.3390/v15010126.
Texto completoRusso, Francesco Paolo, Alberto Zanetto, Elisa Pinto, Sara Battistella, Barbara Penzo, Patrizia Burra y Fabio Farinati. "Hepatocellular Carcinoma in Chronic Viral Hepatitis: Where Do We Stand?" International Journal of Molecular Sciences 23, n.º 1 (2 de enero de 2022): 500. http://dx.doi.org/10.3390/ijms23010500.
Texto completoZaki, Marco Y. W., Ahmed M. Fathi, Samara Samir, Nardeen Eldafashi, Kerolis Y. William, Maiiada Hassan Nazmy, Moustafa Fathy, Upkar S. Gill y Shishir Shetty. "Innate and Adaptive Immunopathogeneses in Viral Hepatitis; Crucial Determinants of Hepatocellular Carcinoma". Cancers 14, n.º 5 (28 de febrero de 2022): 1255. http://dx.doi.org/10.3390/cancers14051255.
Texto completoWang, Ling, Jiabao Geng, Jie Li, Tong Li, Akira Matsumori, Yibin Chang, Fengmin Lu y Hui Zhuang. "The biomarker N-terminal pro-brain natriuretic peptide and liver diseases". Clinical & Investigative Medicine 34, n.º 1 (1 de febrero de 2011): 30. http://dx.doi.org/10.25011/cim.v34i1.14910.
Texto completoSamson, Adel, Matthew J. Bentham, Karen Scott, Gerard Nuovo, Abigail Bloy, Elizabeth Appleton, Robert A. Adair et al. "Oncolytic reovirus as a combined antiviral and anti-tumour agent for the treatment of liver cancer". Gut 67, n.º 3 (15 de noviembre de 2016): 562–73. http://dx.doi.org/10.1136/gutjnl-2016-312009.
Texto completoBrogden, Ruth, Su Wang y Binghong Xu. "Finding the missing millions: Integrating automated viral hepatitis screening in a hospital with care and treatment in a primary care setting." Journal of Clinical Oncology 39, n.º 15_suppl (20 de mayo de 2021): 108. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.108.
Texto completo